Results 141 to 150 of about 26,841 (202)

Proteomic Analysis in Search of New Biomarkers of Immune Thrombocytopenia (ITP)-A Review of Current Data. [PDF]

Proteomes
Boura-Theodorou A, Psatha K, Maniatsi S, Kourti A, Kaiafa G, Aivaliotis M, Makedou K.   +6 more
europepmc   +1 more source

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program. [PDF]

J Adv Pract Oncol
Tarantino M, Dubinski D, Falcon C, Ferber L, Foy P, Johnston S, Kirk S, Lambert MP, Manzoor F, Radulescu V, Sosa IR, Scott P.   +11 more
europepmc   +1 more source

Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial. [PDF]

J Hematol Oncol
Wu R, Gao J, Liu Y, Yu J, Hu S, Liang H, Jiang H, Zhai X, Zhou M, Hao W, Mei H, Li F, Chen Y, Liu W, Yan M, Li R, Xiong J, Zhu Z, Cheng X, Wang T.   +19 more
europepmc   +1 more source

The PI3K-AKT pathway mediates the imbalance of bone marrow macrophage polarization in patients with immune thrombocytopenia. [PDF]

J Transl Med
Shen MZ, Zhao HY, Yu YT, Mo XD, Fu HX, Wang Y, Zhang XH, Huang XJ, Kong Y.   +8 more
europepmc   +1 more source

Cerebral Venous Thrombosis Involving the Vein of Labbé and Left Sigmoid Sinus in a Patient With Immune Thrombocytopenia Treated With Romiplostim: A Case Report and Literature Review. [PDF]

Cureus
Berrocal C, Libreros Mejia I, Ramos Burbano G, Villaquirán FA, Parra Varela A, Caballero Lagares M, Pérez Lafont EM, Carrascal López VA.   +7 more
europepmc   +1 more source

Patient and Physician Experiences in Immune Thrombocytopenia. [PDF]

Adv Ther
Hsu A, Fassett T, Pallagi S, Panch SR.
europepmc   +1 more source

Clinical characteristics and decreased CD4⁺CD25⁺Foxp3⁺ regulatory T cells and IL-35 in pediatric immune thrombocytopenia in a single center. [PDF]

Front Immunol
Yang Y, Lu D, Wu B, Wan L, Zhan X, Zhao A, Tan P, Shi B, Huang J, Lu Y.   +9 more
europepmc   +1 more source

A Comparative Analysis of the Efficacy, Safety and Mechanism of Action of Flebogamma DIF, Fostamatinib and Romiplostim in Immune Thrombocytopenia. [PDF]

Life (Basel)
Akinyemi M, Ravi K, Tian F, Singh B.
europepmc   +1 more source

Etiological Spectrum and Maternal Peripartum Hematologic Outcomes of Thrombocytopenia in Pregnancy: A Retrospective Cohort Study. [PDF]

Medicina (Kaunas)
Erbey B, Atalay CR, Erbey S.
europepmc   +1 more source